HeyJaredThe California Stem Cell Report
An inside and independent look at the Golden State's $12 billion stem cell research program, how it works, who wins and who loses, its conflicts of interest and its changing priorities.
- Indexed issues, last 90 days
- 19
- Latest publication
- Sep 29, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 13, 2026
Latest issues
A $1 Billion Matter: Inside the New Focus Coming Up in California on Stem Cell and Gene Therapy Clinical Trials (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="411" src="https://substackcdn.com/image/fetch/$s_!h52d!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe4ecc159-7f50-48a0-b7f5-30b323a21038_825x411.png" w
New Era at the $12 Billion California Stem Cell Agency with Changing Priorities; Stanford Falls Victim (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="631" src="https://substackcdn.com/image/fetch/$s_!YE4a!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbfd42320-06d5-426a-bf37-07dc23bb7db6_1920x832.jpe
Stem Cell Agency Nixes $12 Million Trial for Ultra-Rare Affliction, Approves Plan to Take More Shots on Goal in Clinical Grants (opens the original)
Read excerpt
SAN DIEGO, Ca. -- Directors of the California stem cell agency today rejected a $12 million proposal for a clinical trial to test a therapy for curing an ultra-rare disease in the womb. They also endorsed a plan to take “more shots on goal” that will involve $1 billion in future clinical-stage funding.The $12 million application involved Stanford and UC San Francisco and an affliction known as Fanconi anemia. The California Stem Cell Report will carry full stories on Thursday’s events in the nex
CIRM Directors Resume Open Session, Taking Up Tens of Millions of Dollars in Awards (opens the original)
Read excerpt
Directors of the $12 billion California stem cell agency resumed their meeting this morning after spending more than an hour in a closed-door personnel session. They have begun to take up grant awards, which are expected to total more than $200 million today.The California Stem Cell Report is a reader-supported publication. To receive new posts and support the work, consider becoming a free or paid subscriber.<input class="email-input" name="email
Closed Door Session Kicks Off Today's Meeting of Stem Cell Agency Board (opens the original)
Read excerpt
Directors of the California stem cell agency went into executive session shortly after beginning their meeting this morning at 8:00 a.m. The subject was salary increases for the chairman of the board and vice chair among other personnel matters. The session has lasted about one hour.At this point it is unclear when it will be concluded and when other business will be taken up. Today's agenda is very full. The meeting could include another executive session involving proprietary information invol
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.